STOCK INCENTIVE PLANS - Schedule of Components of Restricted Stock Units (Details) $ in Millions |
9 Months Ended |
|---|---|
|
Sep. 30, 2026
USD ($)
shares
| |
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
| Unvested restricted stock units (in shares) | shares | 3,319,168 |
| Unrecognized compensation expense | $ 16 |
| Intrinsic value | $ 57 |
| Weighted average remaining life (in years) | 1 year 10 months 28 days |
| Service- Based Units | |
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
| Unvested restricted stock units (in shares) | shares | 2,379,578 |
| Unrecognized compensation expense | $ 15 |
| Intrinsic value | $ 41 |
| Weighted average remaining life (in years) | 1 year 11 months 8 days |
| Performance- Based Units | |
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
| Unvested restricted stock units (in shares) | shares | 939,590 |
| Unrecognized compensation expense | $ 1 |
| Intrinsic value | $ 16 |
| Weighted average remaining life (in years) | 1 year 10 months 2 days |
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for equity-based award excluding option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|